shortagewatch

Home / Systemic hormones / Dexamethasone

ATC H02AB02 · Corticosteroids for Systemic Use

Dexamethasone shortage

As of 31 Oct 2026, Dexamethasone has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Austria, Belgium), covering 15 products.

Countries4/5
Products15packs or presentations
Short since1 Apr 202519 months ago
Earliest return13 Nov 2026company estimate
No return date7products
Main reasonOther
Germany6 packs shortItaly7 packs shortSpainNo reported shortageAustria1 pack shortBelgium1 pack short

Timeline

GermanyItalyAustriaBelgium
20262027Dexahexal 4 mgDexahexal 4 mgDexamethason 1,5 mg JenapharmDexamethason 1,5 mg JenapharmDexa-inject mibe 4 mg/mlDexa-inject mibe 4 mg/mlDexa-inject mibe 4 mg/mlDexa-inject mibe 4 mg/mlDexa-inject mibe 4 mg/mlDexa-inject mibe 4 mg/mlDexa-inject mibe 10 mg/mlDexa-inject mibe 10 mg/mlSOLDESAMSOLDESAMSOLDESAMSOLDESAMSOLDESAMSOLDESAMSOLDESAMSOLDESAMDESAMETASONE KALCEKSDESAMETASONE KALCEKSDESAMETASONE KALCEKSDESAMETASONE KALCEKSDexabene 4 mg - Ampullen, 5 StückDexabene 4 mg - Ampullen, 5 StückAacidexam 5 mg/ml inj. sol. i.m./i.v./i.bursAacidexam 5 mg/ml inj. sol. i.m./i.v./i.burs./i.artic. amp. 10 x 1 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEDexahexal 4 mgH e x a l Aktiengesellschaft12 Feb 202631 Dec 2026Other
Sonstige
DEDexamethason 1,5 mg JenapharmMibe GmbH Arzneimittel1 Jun 202629 Jan 2027Other
Sonstige
DEDexa-inject mibe 4 mg/mlMibe GmbH Arzneimittel1 Jun 202629 Jan 2027Other
Sonstige
DEDexa-inject mibe 4 mg/mlMibe GmbH Arzneimittel1 Jun 202629 Jan 2027Other
Sonstige
DEDexa-inject mibe 4 mg/mlMibe GmbH Arzneimittel1 Jun 202629 Jan 2027Other
Sonstige
DEDexa-inject mibe 10 mg/mlMibe GmbH Arzneimittel2 Sep 202629 Jan 2027Other
Sonstige
ITSOLDESAMLABORATORIO FARMACOLOGICO MILANESE S.R.L.1 Apr 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITSOLDESAMLABORATORIO FARMACOLOGICO MILANESE S.R.L.1 Oct 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale retail)
ITSOLDESAMLABORATORIO FARMACOLOGICO MILANESE S.R.L.4 Dec 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale ospedaliero)
ITSOLDESAMLABORATORIO FARMACOLOGICO MILANESE S.R.L.4 Dec 2025not givenCommercial decision or withdrawal
Motivi commerciali (carenza relativa solo al canale ospedaliero)
ITDESAMETASONE KALCEKSAS KALCEKS1 Aug 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ITDESAMETASONE KALCEKSAS KALCEKS1 Aug 2026not givenIncreased demand
Elevata richiesta/problemi produttivi
ITDESAMETASONE HAMELN announcedHAMELN PHARMA GMBH27 Nov 202631 Jan 2027Increased demand
Elevata richiesta
ATDexabene 4 mg - Ampullen, 5 Stück limitedTeva B.V.5 Oct 2026not givenManufacturing problem
Verzögerung bei der Herstellung
BEAacidexam 5 mg/ml inj. sol. i.m./i.v./i.burs./i.artic. amp. 10 x 1 mlAspen Pharma Trading23 Oct 202613 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Betamethasone Deflazacort Hydrocortisone Methylprednisolone Prednisone Triamcinolone